Poster

K Locke, J Bosley, S Kern, T Gordi, R Beaver

Modeling Supports Determination of First-In-Human Dosing and Rapid Titration to Final Dose for Subcutaneous Administration of LIPO-102.

Presented by Lithera and Rosa at American Conference on Pharmacometrics (ACoP), 2011

Oral Presentation

R Baillie, T Gordi, J Bosley, C Friedrich, A Blood, L Vuong

Whether, How Much, and Why: Integrating Modeling and Systems Biology Approaches To Answer Questions About Use of Ursodiol in Neonates.

Presented by Vitalea and Rosa at the International Conference on Systems Biology (ICSB), 2011

Poster

C Friedrich, R Savic, J Bosley, R Baillie, R Beaver

Comparison of NLME and Mechanistic Physiological Modeling using Examples in Drug Discovery and Development

Presented by Rosa at the Population Approach Group in Europe (PAGE), 2011

Oral Presentation

D Tess, R Baillie

Creating and Using a Physiological Model to Evaluate GPR119 Agonism as a Diabetes Therapy

Presented by Pfizer and Rosa at World PKPD Summit, 2011

Poster

D Tess, A Ghosh, D Chen, P Cornelius, T Maurer, R Baillie, J Bosley, R Beaver

Impact of Modeling on GPR119 Agonist Development

Presented by Pfizer and Rosa at American Conference on Pharmacometrics (ACoP), 2011

Poster

C Friedrich, R Savic, J Bosley, R Baillie, R Beaver

Qualifying Mechanistic Physiological Models for Use in Pharmaceutical Discovery and Development

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2011

Workshop

C Friedrich

Short Course: Optimizing Lead Compound Selection Using Mechanistic Physiological Modeling and Qualifying Mechanistic Physiological Models for Use in Pharmaceutical Discovery and Development

Presented by Rosa at the European Federation for Medicinal Chemistry (EFMC), 2011

Oral Presentation

R Baillie

Modeling Complex Mechanisms of Action in Diabetes Therapy

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2011

"I am grateful to our many clients who have challenged us over the past 15 years to conduct PhysioPD Research on the frontier of science."
—Ron Beaver, PhD, Founder, CEO
Learn more about PhysioPD